The Francis Crick Institute
1-s2.0-S0304419X22000841-main (1).pdf (2.35 MB)

Predicting cancer evolution for patient benefit: Renal cell carcinoma paradigm.

Download (2.35 MB)
journal contribution
posted on 2022-08-04, 10:17 authored by Husayn Ahmed Pallikonda, Samra Turajlic
Evolutionary features of cancer have important clinical implications, but their evaluation in the clinic is currently limited. Here, we review current approaches to reconstruct tumour subclonal structure setting and discuss tumour sampling method and experimental design influence. We describe clear-cell renal cell carcinoma (ccRCC) as an exemplar for understanding and predicting cancer evolutionary dynamics. Finally, we discuss how understanding cancer evolution can benefit patients.


Crick (Grant ID: 10988, Grant title: Turajlic FC001988) Cancer Research UK (Grant ID: 18176, Grant title: CRUK C50947/A18176)